MARINA Trademark

Trademark Overview

On Friday, October 22, 2021, a trademark application was filed for MARINA with the United States Patent and Trademark Office. The USPTO has given the MARINA trademark a serial number of 97087685. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Avidity Biosciences, Inc.. The MARINA trademark is filed in the Pharmaceutical Products category with the following description:

Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
marina

General Information

Serial Number97087685
Word MarkMARINA
Filing DateFriday, October 22, 2021
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202824
Registration DateTuesday, October 24, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesOligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code005
First Use Anywhere DateMonday, August 2, 2021
First Use In Commerce DateMonday, August 2, 2021

Trademark Owner History

Party NameAvidity Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAvidity Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAvidity Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, February 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 26, 2021NEW APPLICATION ENTERED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 21, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022NON-FINAL ACTION WRITTEN
Friday, April 22, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 13, 2023SOU EXTENSION 1 FILED
Monday, February 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 4, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 4, 2023SOU EXTENSION 2 FILED
Friday, August 4, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 10, 2023USE AMENDMENT FILED
Sunday, August 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, August 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

marina oligonucleotide muscle therapies based conjugate diseases antibody central peripheral ophthalmic